Advertisement

Topics

Companies Related to "A Study to Evaluate the Effectiveness and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder." [Most Relevant Company Matches] RSS

01:44 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "A Study to Evaluate the Effectiveness and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder." found in our extensive corporate database of over 50,000 company records.

Showing "Study Evaluate Effectiveness Safety Risperidone Prevention Mood Episodes" Companies 1–25 of 2,800+

Relevant

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...


Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...

Ergonomics and Safety

Ergonomics and Safety provides consulting services to companies for prevention of occupational injuries and illnesses. Ergonomics and Safety applies the following ergonomics tools to industrial and office environments for workplace design and development of safety programs


Polynoma, Inc.

Polynoma, Inc. is an oncology-focused biotechnology company based in San Diego, the United States of America. Polynoma’s lead product candidate is the therapeutic vaccine POL 103A for the treatment of melanoma. The Phase 3 trial of POL 103A was initiated based on two randomized, controlled Phase 2 trials that showed statistically significant efficacy ...

HealthCore Inc.

HealthCore, based in Wilmington, Del., is the clinical outcomes research subsidiary of WellPoint, Inc. HealthCore has a team of highly experienced researchers including physicians, biostatisticians, pharmacists, epidemiologists, health economists and other scientists who study the “real world” safety and effectiveness of drugs, medical devices an...

HealthCore, Inc.

HealthCore, based in Wilmington, Del., is the clinical outcomes research subsidiary of WellPoint. HealthCore has a team of highly experienced researchers including physicians, biostatisticians, pharmacists, epidemiologists, health economists and other scientists who study the "real world" safety and effectiveness of drugs, medical devices and care management interventions. HealthCore offers insig...

HealthCore and WellPoint, Inc.

HealthCore, based in Wilmington, Del., is the clinical outcomes research subsidiary of WellPoint. HealthCore has a team of highly experienced researchers including physicians, biostatisticians, pharmacists, epidemiologists, health economists and other scientists who study the "real world" safety and effectiveness of drugs, medical devices and care management interventions. HealthCore offers insig...

ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centrali...

Vascular Dynamics, Inc.

Vascular Dynamics develops catheter-delivered technologies to bring a better quality of life to patients who are resistant to conventional treatments for hypertension. Vascular Dynamics was one of nine companies chosen in 2012 by the FDA to participate in the Early Feasibility Study IDE Pilot Program. The company is conducting open-label, controlled, multi...

Evaluate, Ltd.

Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. Evaluate supports life science and healthcare companies, financial institutions, consultancies and service providers in their strategic decision-making. Its services include EvaluatePharma, EvaluateClinicalTrials and EvaluateMedTe...

QMed

Since 1983, QMed has led the healthcare industry in developing and using healthcare information systems that improve the health of individuals with chronic diseases and reduce the nation's skyrocketing costs of care. We recognize the value of the physician-patient relationship in this effort and are committed to the personal service required for true participation by physicians and their patients....

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical tri...

BrainCells

BrainCells, INC (BCI) is a leading-edge neurogenesis-based drug discovery and development company targeting novel therapies for depression, mood disorders and other CNS diseases. Neurogenesis is emerging as a fundamental mechanism underlying CNS physiology and provides an opportunity for a paradigm-shifting approach to the treatment of CNS disease. BCI believes that, by targeting neurogenesis me...

Essentys AB

Essentys AB is an innovative biotech company developing therapeutics for the treatment and prevention of diseases in the elderly.The Company is currently focused on the development of its lead product ES 1 in osteoporosis, in which proof of concept has been obtained in clinical phase II studies. ES 1 constitutes a completely new approach to the treatment and prevention of osteoporosis. The data su...

Botvin LifeSkills Training

Botvin LifeSkills Training is a highly effective evidence-based substance abuse and violence prevention program with more than 25 years of peer-reviewed research behind it. The program was developed by Dr. Gilbert J. Botvin, professor of Public Health and Psychiatry at Cornell University's Weill Medical College and director of Cornell's Institute for Prevention Research. LifeSkills Training is inc...

Genta Incorporated

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company’s research platform: DNA/RNA-based Medicines and Small Molecules. Genasense® (oblimersen sodium) Injection is the Company's lead com...

DeltaMetrics

DeltaMetrics is a national research, evaluation, and consulting organization dedicated to the improvement of substance abuse and other behavioral health care treatment. Applying its substantial experience in measurement and treatment outcomes, DeltaMetrics works with payers and providers of behavioral health care treatment to evaluate the performance of their systems of care and to increase their...

SNBL USA, Ltd.

Headquartered in Everett, WA, SNBL USA, Ltd. offers a unique range of safety assessment services to support the drug development process. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, we offer programs ranging from regulatory toxicology to customized study designs and disease models. Our specialized capabi...

BIOCON, INC.

Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and colony management, research study applications, safety testing, custom antibody production or fully-compliant Good Laboratory Practices, BIOCON implements our client’s research initiative with dedicat...

Erimos Technologies, LLC

Erimos has exclusive license for nordihydroguaiaretic acid (NDGA) derivatives from The Johns Hopkins University. We have developed a novel process to extract NDGA from the resin of the leaves of Larrea tridentata, a desert plant indigenous to the southwestern US and Mexico. EM-1421, our lead candidate, is a semi-synthetic derivative of NDGA. It is designed to target specific differences between no...

Koan Health

Koan Health is a healthcare analytics and consulting firm that helps healthcare organizations improve performance in value-based relationships. With Koan's sophisticated predictive analytics, accountable providers and payers understand their networks, provider performance and costs—and target powerful interventions to improve clinical and financial re...

Prevention

Prevention is the #1 healthy lifestyle brand in the U.S., with a magazine audience of more than 10.2 million readers as well as the top online health magazine destination (http://www.prevention.com) with 2.6 million unique visitors each month, 22 million page views and 1.3 million in newsletter distribution. Prevention also publishes branded books—mos...

Ischemix, Inc.

Ischemix is a privately-held, clinical-stage pharmaceutical company developing novel cytoprotective compounds for the prevention and treatment of serious diseases and conditions. The initial focus of the Company is the prevention of acute kidney injury and cardiac injury in patients undergoing cardiac catheterization procedures. Ischemix’ lead product...

Isolagen

Isolagen® Inc., a biotechnology company focused on developing emergent, novel skin and tissue rejuvenation technology for application in certain aesthetic and therapeutic markets. I am pleased to lead Isolagen Inc. as Chairman and Chief Executive Officer. Previously, I served as Chairman, President and CEO of Inamed Corporation, a leading specialty aesthetics company acquired by Allergan Inc. ...

International Bullying Prevention Association

The International Bullying Prevention Association (IBPA) aims to identify and help implement research-based and data-driven programs that reduce bullying in schools. IBPA includes educators, researchers and bullying prevention professionals and practitioners in school violence prevention from around the world. For more information, visit www.stopbullyingworld.org.


More From BioPortfolio on "A Study to Evaluate the Effectiveness and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks